The official publication of Turkish Clinical Biochemistry Association
Objective: This study aimed to evaluate the frequency of repeat lipoprotein(a) testing, determine whether repeated measurements changed risk classification, assess the clinical significance of observed changes using the reference change value, and investigate whether the...
Aim: Lipid profile is used to determine the risk of cardiovascular diseases (CVD) and to monitor treatment. Reference change value (RCV) represents the clinical significance of the variation between the results of two consecutive tests and laboratory test results exceeding...
Objectives: This study aims to analyze the turnaround time (TAT) of intraoperative PTH (parathyroid hormone) testing and to support surgical success with objective criteria by calculating reference change values (RCV).
Methods: TAT analysis was...
Objective: In the study, it was aimed to determine the harmony of LDL-C levels determined by enzymatic(direct) and computational method, to have an idea about the optimal request frequency by examining the significance of the percentage changes of repeated LDL-C measurements...
Objective: The aim of study was to determine unnecessary repeated total prostate specific antigen(tPSA) according to minimum retest interval and to evaluate the change between consecutive measurement results with RCV.
Material and Methods: According...
Aim: Measurement of cardiac troponins is of great importance in the diagnosis and follow-up of acute myocardial infarction. The diagnostic specificity of myocardial infarction has increased with algorithms including serial troponin measurements. It is important that the...
Objective: HDL is considered as anti-atherogenic and it exerts this effect with reverse cholesterol transport and with the contribution of enzymes such as paraoxonase and platelet activating factor acetylhydrolase. Data on biological variation can be used to determine the...
Fully Diamond OA with no APCs and no submission fees. Your research is freely available to readers worldwide from the day it publishes.
Double-blind peer review from an active editorial team returns a first decision in about 30 days, keeping your manuscript moving.
Backed by the Turkish Clinical Biochemistry Association, JTCB welcomes submissions from researchers worldwide and reaches an international laboratory audience.
Method validation, analyzer comparisons, reference intervals, quality indicators, preanalytical studies, and instructive clinical case reports.
All manuscripts publish in English and follow ICMJE and COPE guidelines, with Crossref DOIs and TR Dizin indexing ensuring global discoverability.